15.01.2013
- Swiss drugmaker Roche has hired a leading American academic in a bid to revive part of its research operations which have struggled to shake off a string of high-profile and costly...
09.01.2013
- Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...
08.01.2013
- British drugmaker Shire has agreed to buy Lotus Tissue Repair, a U.S. biotechnology company developing the first treatment for a rare genetic disorder that causes extremely fragile...
08.01.2013
- Sartorius Stedim Biotech, a pharmaceutical and biotech supplier, today announced a substantial expansion of its product rray in the cell culture range. The company signed a...
08.01.2013
- Hookipa Biotech, a vaccine biotech start up pioneering a new class of vaccines, today announced the appointment of two new members to its management team: Thomas P. Monath as Chief...
08.01.2013
- Actelion, Europe's biggest biotech company, is sticking to its forecast for core earnings to return to growth from 2014 as cost cuts and a new heart and lung treatment offset...
08.01.2013
- Celgene on Monday forecast 2013 profit in line with Wall Street projections, introduced a long-term outlook for 2017, and said results from two late-stage trials of a drug for the...
05.01.2013
- A measure to require special labeling of genetically modified foods appeared virtually certain to qualify for the ballot in Washington state on Friday, two months after voters in...
04.01.2013
- Italian biopharmaceutical company Philogen has signed a worldwide license agreement with drug firm Pfizer for the development of Dekavil, an experimental treatment for autoimmune...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
